Cargando…
Investigation of the anti-inflammatory effects of native potential probiotics as supplementary therapeutic agents in an in-vitro model of inflammation
BACKGROUND: IBD is considered an inflammatory disease with abnormal and exaggerated immune responses. To control the symptoms, different theraputic agents could be used, however, utilizing the agents with the least side effects could be important. Probiotics as beneficial microorganisms are one of t...
Autores principales: | Aghamohammad, Shadi, Sepehr, Amin, Miri, Seyedeh Tina, Najafi, Saeideh, Pourshafie, Mohammad R., Rohani, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515064/ https://www.ncbi.nlm.nih.gov/pubmed/37735396 http://dx.doi.org/10.1186/s12906-023-04153-y |
Ejemplares similares
-
The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
Ameliorating inflammation in an in vitro model by screening the anti-inflammatory and immunomodulatory roles of putative probiotics in inflammatory bowel disease
por: Aghamohammad, Shadi, et al.
Publicado: (2023) -
Anti‐inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease
por: Salimi, Afsaneh, et al.
Publicado: (2022)